Clinical trials
Completed Hepatitis D, Chronic trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| EIT Pharma, Inc. | 2 |
| Gilead Sciences | 2 |
| Center of target therapy | 1 |
| Janssen Research & Development, LLC | 1 |
| Merck Sharp & Dohme LLC | 1 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 1 |
| Replicor Inc. | 1 |
| Shanghai HEP Pharmaceutical Co., Ltd. | 1 |
| Soroka University Medical Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis D, Chronic | 15 |
| Hepatitis B, Chronic | 3 |
| Hepatitis D | 3 |
| Hepatitis B | 2 |
| Fibrosis | 1 |
| Glomerulonephritis | 1 |
| Polyarteritis Nodosa | 1 |
Trials
Showing 26 to 15 of 15. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.